{"id":946487,"date":"2026-03-24T09:44:35","date_gmt":"2026-03-24T13:44:35","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\/"},"modified":"2026-03-24T09:44:35","modified_gmt":"2026-03-24T13:44:35","slug":"icon-and-advarra-introduce-new-research-ready-connected-site-network-model","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\/","title":{"rendered":"ICON and Advarra Introduce New \u2018Research-Ready,\u2019 Connected Site Network Model"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>ICON and Advarra Introduce New \u2018Research-Ready,\u2019 Connected Site Network Model<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><i>Partnership will integrate ICON\u2019s clinical trial technology with Advarra\u2019s purpose-built system for research sites, embedded across a broad, deeply established global network.<\/i><\/li>\n<li><i>Partnership will reduce administrative friction, accelerate study startup, and increase clinical trial participation.<\/i><\/li>\n<\/ul>\n<p>DUBLIN &amp; COLUMBIA, Md.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.iconplc.com%2F&amp;esheet=54460424&amp;newsitemid=20260324957133&amp;lan=en-US&amp;anchor=ICON+plc&amp;index=1&amp;md5=d78fec72109c2360a67464831f5c445a\">ICON plc<\/a> (NASDAQ: ICLR), a world-leading clinical research organisation, and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.advarra.com%2F&amp;esheet=54460424&amp;newsitemid=20260324957133&amp;lan=en-US&amp;anchor=Advarra&amp;index=2&amp;md5=65710053c3bb75e3223800590bf9a233\">Advarra<\/a>, the market leader in regulatory reviews and a leading provider of connected, intelligence-powered research technology, have entered a definitive partnership agreement to introduce a new \u2018research-ready,\u2019 connected site network model for clinical trials.<\/p>\n<p>\nThe partnership will integrate ICON\u2019s global clinical trial solutions and services with Advarra\u2019s site <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.advarra.com%2Fsolutions%2Fsites%2Fctms%2F&amp;esheet=54460424&amp;newsitemid=20260324957133&amp;lan=en-US&amp;anchor=CTMSs&amp;index=3&amp;md5=10aa0387c470ff298062ad91572f437a\">CTMSs<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.advarra.com%2Fsolutions%2Fsites%2Fereg%2F&amp;esheet=54460424&amp;newsitemid=20260324957133&amp;lan=en-US&amp;anchor=eISF&amp;index=4&amp;md5=ee9b501f88f9ba50d2f77522472156d6\">eISF<\/a>, and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.advarra.com%2Fsolutions%2Fsites%2Fesource%2F&amp;esheet=54460424&amp;newsitemid=20260324957133&amp;lan=en-US&amp;anchor=eSource&amp;index=5&amp;md5=e461170c5ace0ab91ed0da0db553f1ff\">eSource<\/a> systems, which are already used by more than 50,000 investigators worldwide, including researchers at 90 of the top 125 academic medical centers, 90 percent of NCI-Designated Cancer Centers, and the top site networks. This approach leverages Advarra\u2019s <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.advarra.com%2Fsolutions%2Fsponsors-cros%2Fstudy-collaboration-solutions%2Fadvarra-study-collaboration%2F&amp;esheet=54460424&amp;newsitemid=20260324957133&amp;lan=en-US&amp;anchor=Study+Collaboration&amp;index=6&amp;md5=57938aa4dc76d914d45d9ddd796e60df\">Study Collaboration<\/a> as the connector to ICON\u2019s proprietary technology to create a shared operating environment for ICON studies that reduces administrative friction, accelerates study startup, and increases clinical trial participation.<\/p>\n<p>\nAdvarra will also provide ICON with deep operational intelligence through Study Collaboration, built on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.advarra.com%2Fplatform%2Fbraid%2F&amp;esheet=54460424&amp;newsitemid=20260324957133&amp;lan=en-US&amp;anchor=Braid&amp;index=7&amp;md5=25081105affeb630cfe02ae071633a40\">Braid<\/a>\u2122, Advarra\u2019s data and AI platform that draws on operational insights from its IRB and clinical trial systems. The intelligence will help ICON further optimise protocol design, improve forecasting and study planning, and strengthen research site identification and feasibility decisions. With a clearer understanding of research site capacity, workflow realities, and historical operational patterns, studies can be planned more realistically and executed with fewer downstream adjustments.<\/p>\n<p>\nIn addition, ICON and Advarra will work together to expand access to clinical trials by enabling more research sites worldwide to support today\u2019s increasingly complex study requirements. The companies plan to equip emerging and research-na\u00efve sites, along with select sites working with ICON, with Advarra\u2019s site technology, helping standardise operations and reduce manual processes. This will provide sponsors with a way to accelerate study startup and engage a broader and more geographically diverse set of research sites, and improve patient recruitment and retention.<\/p>\n<p>\n\u201cResearch sites should not have to adapt their operations for every new study or sponsor, and ICON and Advarra are focused on meeting sites where they are, prioritising their needs and removing that burden through this partnership,\u201d said Barry Balfe, CEO of ICON plc. \u201cBy aligning ICON\u2019s workflows with the systems sites already use every day, we\u2019re advancing a more practical and scalable way to run trials that reduces administrative burden on sites.\u201d<\/p>\n<p>\nAdvarra\u2019s systems serve as the lifeblood of site operations\u2014from financial management to regulatory compliance and participant visit workflows. In the last year, Advarra\u2019s site systems were used to manage over four billion dollars in trial invoice value, over three million patient visits, and over two million electronic documents and signatures. For research sites, this partnership means studies can be managed within the systems they already use day to day, without duplicating work across platforms. Study information, training materials, document exchange, and enrollment activity will feed seamlessly into site workflows, while ICON and sponsor teams gain shared, real-time visibility into how their studies are progressing, from startup through conduct.<\/p>\n<p>\n\u201cSites do their best work when they can stay focused on patients and study delivery, not on managing fragmented processes,\u201d said Gadi Saarony, CEO of Advarra. \u201cBy integrating ICON\u2019s technology with the Advarra systems sites already use, this partnership allows sites to work in their native systems, reducing rework, improving consistency, and streamlining workflows. For sponsors, it means trials can move forward with greater speed and confidence, helping promising therapies move through development more efficiently and reach patients sooner.\u201d<\/p>\n<p><b>About ICON plc<\/b><\/p>\n<p>\nICON plc is a world-leading clinical research organisation. Offering deep operational and medical expertise we accelerate innovation, driving emerging therapies forward to improve patient outcomes. From molecule to medicine, we deliver integrated consulting, clinical development, commercialisation and post-marketing solutions to pharmaceutical, biotechnology, medical device, government and public health organisations worldwide. With headquarters in Dublin, Ireland, ICON employed approximately 40,100 employees in 97 locations in 55 countries as of December 31, 2025. For further information about ICON, visit: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.iconplc.com%2F&amp;esheet=54460424&amp;newsitemid=20260324957133&amp;lan=en-US&amp;anchor=www.iconplc.com&amp;index=8&amp;md5=ebf9d24eec9c28150750ef9e36e834ab\">www.iconplc.com<\/a>.<\/p>\n<p><b>About Advarra<\/b><\/p>\n<p>\nAdvarra provides the platform, insights, and expertise that make clinical trials more efficient and connected. As the leading independent IRB, we bring more than 40 years of trusted oversight to the industry, setting the standard for ethical reviews while building the largest collection of digitized protocols and operational data. This combined intelligence guides the protocol\u2019s entire journey\u2014from design through review, activation, and conduct\u2014fueling a smarter, more adaptive research ecosystem.<\/p>\n<p>\nBacked by decades of partnership with research sites, Advarra delivers the core systems and services that 50,000 investigators and their study teams depend on for optimal trial operations. Integrated with our solutions for study design, startup, and conduct, these capabilities create a collaborative technology platform trusted by sponsors and CROs globally.<\/p>\n<p>\nBy designing AI-powered workflows that streamline operations, reduce administrative burden, and promote transparency for all study stakeholders, we\u2019re reimagining what\u2019s possible in clinical research. Learn more at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.advarra.com&amp;esheet=54460424&amp;newsitemid=20260324957133&amp;lan=en-US&amp;anchor=www.advarra.com&amp;index=9&amp;md5=5bb814c77d7776b229c083ac789efbdf\">www.advarra.com<\/a>.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260324957133r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260324957133\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260324957133\/en\/<\/a><\/span><\/p>\n<p><b>Media contacts:<br \/>\n<\/b><br \/><b>ICON:<br \/>\n<\/b><br \/>Lisa Henry (GMT time zone)<br \/>\n<br \/>Weber Shandwick (PR adviser)<br \/>\n<br \/>+447785 458203<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:lhenry@webershandwick.com\">lhenry@webershandwick.com <\/a><\/p>\n<p>\nICON Press Office<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:iconnews@webershandwick.com\">iconnews@webershandwick.com<\/a><\/p>\n<p><b>Advarra:<br \/>\n<\/b><br \/>Laurie Thackeray<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:laurie.thackeray@advarra.com\">laurie.thackeray@advarra.com <\/a><\/p>\n<p>\nAdvarra Media Relations<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:mediarelations@advarra.com\">mediarelations@advarra.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> North America United States Ireland United Kingdom Europe Maryland<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Technology Research Medical Devices Clinical Trials Health Pharmaceutical Data Management Science Artificial Intelligence<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260324957133\/en\/2754494\/3\/advarra-icon-stacked.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>ICON and Advarra Introduce New \u2018Research-Ready,\u2019 Connected Site Network Model Partnership will integrate ICON\u2019s clinical trial technology with Advarra\u2019s purpose-built system for research sites, embedded across a broad, deeply established global network. Partnership will reduce administrative friction, accelerate study startup, and increase clinical trial participation. DUBLIN &amp; COLUMBIA, Md.&#8211;(BUSINESS WIRE)&#8211;ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, and Advarra, the market leader in regulatory reviews and a leading provider of connected, intelligence-powered research technology, have entered a definitive partnership agreement to introduce a new \u2018research-ready,\u2019 connected site network model for clinical trials. The partnership will integrate ICON\u2019s global clinical trial solutions and services with Advarra\u2019s site CTMSs, eISF, and eSource systems, which are already used by more than 50,000 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ICON and Advarra Introduce New \u2018Research-Ready,\u2019 Connected Site Network Model&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-946487","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ICON and Advarra Introduce New \u2018Research-Ready,\u2019 Connected Site Network Model - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ICON and Advarra Introduce New \u2018Research-Ready,\u2019 Connected Site Network Model - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ICON and Advarra Introduce New \u2018Research-Ready,\u2019 Connected Site Network Model Partnership will integrate ICON\u2019s clinical trial technology with Advarra\u2019s purpose-built system for research sites, embedded across a broad, deeply established global network. Partnership will reduce administrative friction, accelerate study startup, and increase clinical trial participation. DUBLIN &amp; COLUMBIA, Md.&#8211;(BUSINESS WIRE)&#8211;ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, and Advarra, the market leader in regulatory reviews and a leading provider of connected, intelligence-powered research technology, have entered a definitive partnership agreement to introduce a new \u2018research-ready,\u2019 connected site network model for clinical trials. The partnership will integrate ICON\u2019s global clinical trial solutions and services with Advarra\u2019s site CTMSs, eISF, and eSource systems, which are already used by more than 50,000 &hellip; Continue reading &quot;ICON and Advarra Introduce New \u2018Research-Ready,\u2019 Connected Site Network Model&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-24T13:44:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260324957133r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ICON and Advarra Introduce New \u2018Research-Ready,\u2019 Connected Site Network Model\",\"datePublished\":\"2026-03-24T13:44:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\\\/\"},\"wordCount\":933,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260324957133r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\\\/\",\"name\":\"ICON and Advarra Introduce New \u2018Research-Ready,\u2019 Connected Site Network Model - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260324957133r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-03-24T13:44:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260324957133r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260324957133r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ICON and Advarra Introduce New \u2018Research-Ready,\u2019 Connected Site Network Model\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ICON and Advarra Introduce New \u2018Research-Ready,\u2019 Connected Site Network Model - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\/","og_locale":"en_US","og_type":"article","og_title":"ICON and Advarra Introduce New \u2018Research-Ready,\u2019 Connected Site Network Model - Market Newsdesk","og_description":"ICON and Advarra Introduce New \u2018Research-Ready,\u2019 Connected Site Network Model Partnership will integrate ICON\u2019s clinical trial technology with Advarra\u2019s purpose-built system for research sites, embedded across a broad, deeply established global network. Partnership will reduce administrative friction, accelerate study startup, and increase clinical trial participation. DUBLIN &amp; COLUMBIA, Md.&#8211;(BUSINESS WIRE)&#8211;ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, and Advarra, the market leader in regulatory reviews and a leading provider of connected, intelligence-powered research technology, have entered a definitive partnership agreement to introduce a new \u2018research-ready,\u2019 connected site network model for clinical trials. The partnership will integrate ICON\u2019s global clinical trial solutions and services with Advarra\u2019s site CTMSs, eISF, and eSource systems, which are already used by more than 50,000 &hellip; Continue reading \"ICON and Advarra Introduce New \u2018Research-Ready,\u2019 Connected Site Network Model\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\/","og_site_name":"Market Newsdesk","article_published_time":"2026-03-24T13:44:35+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260324957133r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ICON and Advarra Introduce New \u2018Research-Ready,\u2019 Connected Site Network Model","datePublished":"2026-03-24T13:44:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\/"},"wordCount":933,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260324957133r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\/","name":"ICON and Advarra Introduce New \u2018Research-Ready,\u2019 Connected Site Network Model - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260324957133r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-03-24T13:44:35+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260324957133r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260324957133r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icon-and-advarra-introduce-new-research-ready-connected-site-network-model\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ICON and Advarra Introduce New \u2018Research-Ready,\u2019 Connected Site Network Model"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/946487","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=946487"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/946487\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=946487"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=946487"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=946487"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}